E-LIB Suche - Ergebnisse für: Recondo, Gonzalo

1

The role of angiogenesis inhibitors associated with tyrosin..:

Motta-Guerrero, Rodrigo ; Recondo, Gonzalo ; Cardona, Andres...
Critical Reviews in Oncology/Hematology. 196 (2024) - p. 104294 , 2024

Link: https://doi.org/10.1016/..

2

Geographic differences in lung cancer: focus on carcinogens..:

Laguna, Juan Carlos ; García-Pardo, Miguel ; Alessi, Joao...
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

3

Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune..:

Alessi, Joao V. ; Wang, Xinan ; Elkrief, Arielle...
Journal of Thoracic Oncology. 18 (2023) 11 - p. 1524-1537 , 2023

Link: https://doi.org/10.1016/..

4

MET alterations in NSCLC—Current Perspectives and Future Ch..:

Remon, Jordi ; Hendriks, Lizza E.L. ; Mountzios, Giannis...
Journal of Thoracic Oncology. 18 (2023) 4 - p. 419-435 , 2023

Link: https://doi.org/10.1016/..

5

Argentine consensus recommendations for lung cancer screeni..:

Boyeras, Iris ; Roberti, Javier ; Seijo, Mariana...
BMJ Open. 13 (2023) 2 - p. e068271 , 2023

Link: https://doi.org/10.1136/..

6

Clinicopathologic and Genomic Factors Impacting Efficacy of..:

Alessi, Joao V. ; Elkrief, Arielle ; Ricciuti, Biagio...
Journal of Thoracic Oncology. 18 (2023) 6 - p. 731-743 , 2023

Link: https://doi.org/10.1016/..

7

PD.01.03 Genomic Landscape of Primary-Resistance to Osimert..:

Chamorro, Diego ; Cardona, Andres ; Rodriguez, July...
Journal of Thoracic Oncology. 18 (2023) 3 - p. S4 , 2023

Link: https://doi.org/10.1016/..

8

Genomic Landscape of Primary Resistance to Osimertinib Amon..:

Chamorro, Diego F. ; Cardona, Andrés F. ; Rodríguez, July...
Targeted Oncology. 18 (2023) 3 - p. 425-440 , 2023

Link: https://doi.org/10.1007/..

9

p.G12C KRAS mutation prevalence in non-small cell lung canc..:

Ruiz-Patiño, Alejandro ; Rodríguez, July ; Cardona, Andrés F....
Translational Oncology. 15 (2022) 1 - p. 101276 , 2022

Link: https://doi.org/10.1016/..

10

Mechanisms of Resistance to First-Line Osimertinib in Hispa..:

Cardona, Andrés F. ; Ruiz-Patiño, Alejandro ; Recondo, Gonzalo...
Clinical Lung Cancer. 23 (2022) 6 - p. 522-531 , 2022

Link: https://doi.org/10.1016/..

11

STK11 and KEAP1 mutations in non-small cell lung cancer pat..:

Cordeiro de Lima, Vladmir C. ; Corassa, Marcelo ; Saldanha, Erick...
Lung Cancer. 170 (2022) - p. 114-121 , 2022

Link: https://doi.org/10.1016/..

12

Caracterización molecular por secuenciación de nueva genera..:

Spotti, Martina ; Minatta, José N. ; Rizzo, Manglio M....
Oncología Clínica. 27 (2022) 2 - p. , 2022

Link: https://doi.org/10.56969..

13

Durvalumab After Chemoradiation for Unresectable Stage III ..:

Raez, Luis E. ; Arrieta, Oscar ; Chamorro, Diego F....
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

14

Diminished Efficacy of Programmed Death-(Ligand)1 Inhibitio..:

Ricciuti, Biagio ; Arbour, Kathryn C. ; Lin, Jessica J....
Journal of Thoracic Oncology. 17 (2022) 3 - p. 399-410 , 2022

Link: https://doi.org/10.1016/..

15

When Tissue is an Issue the Liquid Biopsy is Nonissue: A Re..:

Rodríguez, July ; Avila, Jenny ; Rolfo, Christian...
Oncology and Therapy. 9 (2021) 1 - p. 89-110 , 2021

Link: https://doi.org/10.1007/..